Related Experiment Video

Updated: Jun 13, 2026

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

Specific killing of Rb mutant cancer cells by inactivating TSC2

Binghui Li1, Gabriel M Gordon, Charles H Du

  • 1Ben May Department for Cancer Research, The University of Chicago, 929 E. 57th Street, Chicago, IL 60637, USA.

Cancer Cell
|May 19, 2010
PubMed

Insights

Retinoblastoma (Rb) tumor suppressor inactivation is common in cancers. Targeting TSC2 (gig) alongside Rb (rbf) specifically kills Rb-mutant cancer cells by increasing oxidative stress, inhibiting tumor growth.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The retinoblastoma (Rb) tumor suppressor protein is frequently inactivated in various human cancers.
  • Identifying novel therapeutic targets for Rb-mutant cancers is a critical unmet need in oncology.

Purpose of the Study:

  • To identify genes that can specifically target cancers with inactivated Rb.
  • To investigate the synergistic effect of inactivating Rb and TSC2 (gig) in cancer cells.

Main Methods:

  • Conducted a genetic screen in Drosophila to identify genes that cooperate with loss of Rb.
  • Utilized Drosophila models to study the effects of combined Rb and TSC2 inactivation on cell death and tumor growth.
  • Analyzed cellular stress markers, including oxidative stress, protein synthesis, lipid synthesis, and SOD2 induction.

Main Results:

  • Identified gig (Drosophila TSC2) as a gene that synergistically induces cell death when co-inactivated with rbf (Drosophila Rb).
  • Demonstrated that TSC2 inactivation specifically kills Rb-mutant cancer cells under stress conditions, leading to inhibited tumor growth.
  • Showed that combined Rb and TSC2 inactivation increases cellular oxidative stress through enhanced protein synthesis, impaired de novo lipid synthesis, and reduced SOD2 induction.

Conclusions:

  • Concomitant inactivation of Rb and TSC2 represents a potential therapeutic strategy for Rb-deficient cancers.
  • The observed cancer cell killing is mediated by synergistic induction of oxidative stress via dysregulated metabolic pathways and compromised antioxidant defense.

More Related Videos

Inducible and Reversible Dominant-negative (DN) Protein Inhibition08:35

Inducible and Reversible Dominant-negative (DN) Protein Inhibition

Published on: January 7, 2019

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...